Comparison of nodal irradiation dose using radiotherapy for patients with thoracic esophageal cancer

Zhang,Ni; Gu,Min; Wang,Jiahao; Wu,Shixiu

doi:10.3892/ol.2019.11178

Comparison of nodal irradiation dose using radiotherapy for patients with thoracic esophageal cancer

Authors:
- Ni Zhang
- Min Gu
- Jiahao Wang
- Shixiu Wu
View Affiliations

Affiliations: Department of Radiation Oncology, Hangzhou Cancer Hospital, Hangzhou, Zhejiang 310002, P.R. China
Published online on: December 3, 2019 https://doi.org/10.3892/ol.2019.11178
Pages: 1042-1050

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to compare incidental nodal irradiation (INI) doses using volume‑modulated arc therapy (VMAT), 5‑field intensity‑modulated radiotherapy (5F‑IMRT) and 3D‑conformal radiotherapy (3D‑CRT) treatment plans for patients with thoracic esophageal cancer (EC). A total of 15 patients with thoracic EC were selected for participation between October 2016 and July 2017 at the Hangzhou Cancer Hospital. Regional lymph nodal stations were contoured according to 3D CT‑based images of the Japan Esophageal Society Guidelines. All patients were treated with 60 Gy using VMAT, 5F‑IMRT and 3D‑CRT plans. Dose‑volume histograms of planning target volume (PTV), lung, heart, spinal cord and incidental nodal irradiation were compared between the three plans. 5F‑IMRT was superior in PTV_V95% (the volume of the PTV receiving 95% of the prescription dose, P=0.003) and the VMAT plan was best in terms of conformal index (P=0.005). V20 and V30 were reduced by 10.7‑22.6% (P=0.002) and 12.8‑21% (P=0.026), respectively, in normal lung tissue using the VMAT plan. 5F‑IMRT demonstrated the lowest maximum dose (Dmax) for the spinal cord (P=0.037). For the INI, 3D‑CRT exhibited the highest equivalent uniform dose (EUD) values for 106pre (P=0.014) and 106tb‑L (P=0.03) in upper‑thoracic EC. The mean EUD of all lymph nodal regions in middle‑thoracic EC were >40 Gy in VMAT and 5F‑IMRT plans; the VMAT plan had higher EUD values in lower‑thoracic EC compared with 5F‑IMRT, 3D‑CRT plans for INI. VMAT were comparable to the 5F‑IMRT plan with respect to dosimetric characteristics for planning and INI doses to thoracic nodal levels NO 105‑112 are considerable for thoracic EC.

View Figures

View References

1	American Cancer Society. Esophageal cancer, . Atlanta, GA: American Cancer Society; 2007
2	Djarv T, Lagergren J, Blazeby JM and Lagergren P: Long-term health-related quality of life following surgery for esophageal cancer. Br J Surg. 95:1121–1126. 2008. View Article : Google Scholar : PubMed/NCBI
3	Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA and Kelsen DP: INT0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol. 20:1167–1174. 2002. View Article : Google Scholar : PubMed/NCBI
4	Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, et al: Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation therapy oncology group. JAMA. 281:1623–1627. 1999. View Article : Google Scholar : PubMed/NCBI
5	Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, Pisansky TM, Willett CG, Hoffman JP, Owen JB and Hanks GE: Outcome of patients receiving radiation for cancer of the esophagus: Results of the 1992–1994 patterns of care study. J Clin Oncol. 18:455–462. 2000. View Article : Google Scholar : PubMed/NCBI
6	Smith TJ, Ryan LM, Douglass HO Jr, Haller DG, Dayal Y, Kirkwood J, Tormey DC, Schutt AJ, Hinson J and Sischy B: Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: A study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys. 42:269–276. 1998. View Article : Google Scholar : PubMed/NCBI
7	Muijs C, Smit J, Karrenbeld A, Beukema J, Mul V, van Dam G, Hospers G, Kluin P, Langendijk J and Plukker J: Residual tumor after neoadjuvant chemoradiation outside the radiation therapy target volume: A new prognostic factor for survival in esophageal cancer. Int J Radiat Oncol Biol Phys. 88:845–852. 2014. View Article : Google Scholar : PubMed/NCBI
8	Ji K, Zhao L, Yang C, Meng M and Wang P: Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation. Radiat Oncol. 7:2002012. View Article : Google Scholar : PubMed/NCBI
9	Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, Jamema SV, Vanetti E, Clivio A, Nicolini G and Fogliata A: A treatment planning study comparing volumetric arc modulation with rapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother. Oncol. 89:180–191. 2008.
10	Guckenberger M, Richter A, Krieger T, Wilbert J, Baier K and Flentje M: Is a single arc sufficient in volumetric-modulated arc therapy (VMAT) for complex-shaped target volumes? Radiother. Oncol. 93:259–265. 2009.
11	Shaffer R, Morris WJ, Moiseenko V, Welsh M, Crumley C, Nakano S, Schmuland M, Pickles T and Otto K: Volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for simultaneous maximal intraprostatic Boost: A planning comparison study. Clin Oncol (R Coll Radiol). 21:401–407. 2009. View Article : Google Scholar : PubMed/NCBI
12	ICRU Report 62, . Prescribing, Recording, and Reporting Photon Beam Therapy. (Supplement to ICRU Report 50):21:1999.
13	Japanese Society for Esophageal Disease, . Guide lines for the clinical and pathologic studies for carcinoma of the esophagus. Jpn J Surg. 1976:79–86. 1976.
14	Japan Esophageal Society, . Japanese classification of esophageal cancer, 11th Edition: part I. Esophagus. 6:71–94. 2009. View Article : Google Scholar
15	Harris KM, Adams H, Lloyd DC and Harvey DJ: The effect on apparent size of simulated pulmonary nodules of using three standard CT window settings. Clin Radiol. 47:241–244. 1993. View Article : Google Scholar : PubMed/NCBI
16	Otto K: Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 35:310–317. 2008. View Article : Google Scholar : PubMed/NCBI
17	Fogliata A, Yartsev S, Nicolini G, Clivio A, Vanetti E, Wyttenbach R, Bauman G and Cozzi L: On the performances of intensity modulated protons, RapidArc, helical tomotherapy for selected paediatric cases. Radiat Oncol. 4:22009. View Article : Google Scholar : PubMed/NCBI
18	Fogliata A, Clivio A, Nicolini G, Vanetti E and Cozzi L: Intensity modulation with photons for benign intracranial tumours: A planning comparison of volumetric single arc, helical arc and fixed gantry techniques. Radiother Oncol. 89:254–262. 2008. View Article : Google Scholar : PubMed/NCBI
19	Fenkell L, Kaminsky I, Breen S, Huang S, Van Prooijen M and Ringash J: Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. Radiother. Oncol. 89:287–291. 2009.
20	Yin Y, Chen J, Xing L, Dong X, Liu T, Lu J and Yu J: Applications of IMAT in cervical esophageal cancer radiotherapy: A comparison with fixed-field IMRT in dosimetry and implementation. J Appl Clin Med Phys. 12:48–57. 2011. View Article : Google Scholar
21	Van Benthuysen L, Hales L and Podgorsak MB: Volumetric modulated arc therapy vs. IMRT for the treatment of distal esophageal cancer. Med Dosim. 36:404–409. 2011. View Article : Google Scholar : PubMed/NCBI
22	Shimada H, Kitabayashi H, Nabeya Y, Okazumi S, Matsubara H, Funami Y, Miyazawa Y, Shiratori T, Uno T, Itoh H and Ochiai T: Treatment response and prognosis of patients after recurrence of esophageal cancer. Surgery. 133:24–31. 2003. View Article : Google Scholar : PubMed/NCBI
23	Greenlee RT, Hill-Harmon MB, Murray T and Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001. View Article : Google Scholar : PubMed/NCBI
24	Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T and Hatakeyama K: Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg. 198:205–211. 2004. View Article : Google Scholar : PubMed/NCBI
25	Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC and Chia-Hsien Cheng J: Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 81:593–599. 2011. View Article : Google Scholar
26	Zhao KL, Ma JB, Liu G, Wu KL, Shi XH and Jiang GL: Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: Is elective nodal irradiation necessary? Int J Radiation Oncology Biol Phys. 76:446–451. 2010. View Article : Google Scholar
27	Welsh J, Settle SH, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z and Ajani JA: Failure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer. 118:2632–2640. 2012. View Article : Google Scholar : PubMed/NCBI
28	Zhao L, Chen L, Ten Haken R, Chetty I, Chapet O, Hayman JA and Kong FM: Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located. Radiother Oncol. 82:153–159. 2007. View Article : Google Scholar : PubMed/NCBI
29	Kepka L, Maciejewski B and Withers RH: Does incidental irradiation with doses below 50 Gy effectively reduce isolated nodal failures in non-small-cell lung cancer: Dose-response relationship. Int J Radiat Oncol Biol Phys. 73:1391–1396. 2009. View Article : Google Scholar : PubMed/NCBI
30	Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, Zhang Z and Liu X: Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiother Oncol. 95:229–233. 2010. View Article : Google Scholar : PubMed/NCBI
31	Chen J, Liu S, Pan J, Zheng X, Zhu K, Zhu J, Xiao J and Ying M: The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg. 36:480–486. 2009. View Article : Google Scholar : PubMed/NCBI